These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2380110)

  • 1. A54145 a new lipopeptide antibiotic complex: microbiological evaluation.
    Counter FT; Allen NE; Fukuda DS; Hobbs JN; Ott J; Ensminger PW; Mynderse JS; Preston DA; Wu CY
    J Antibiot (Tokyo); 1990 Jun; 43(6):616-22. PubMed ID: 2380110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance.
    Goto S; Kuwahara S; Okubo N; Zenyoji H
    J Antibiot (Tokyo); 1968 Feb; 21(2):119-25. PubMed ID: 4299887
    [No Abstract]   [Full Text] [Related]  

  • 3. The gram-positive cocci: III. Resistance to antibiotics.
    Musher DM
    Hosp Pract (Off Ed); 1988 May; 23(5):105-7, 111-2, 117-8 passim. PubMed ID: 3131351
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities.
    Liang JH; Li XL; Wang H; An K; Wang YY; Xu YC; Yao GW
    Eur J Med Chem; 2012 Mar; 49():289-303. PubMed ID: 22301216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic production by new form-genera of the Actinomycetales. I. Sporangiomycin, an antibacterial agent isolated from Planomonospora parontospora var. antibiotica var. nov.
    Thiemann JE; Coronelli C; Pagani H; Beretta G; Tamoni G
    J Antibiot (Tokyo); 1968 Sep; 21(9):525-31. PubMed ID: 4388267
    [No Abstract]   [Full Text] [Related]  

  • 7. Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens.
    Or YS; Clark RF; Wang S; Chu DT; Nilius AM; Flamm RK; Mitten M; Ewing P; Alder J; Ma Z
    J Med Chem; 2000 Mar; 43(6):1045-9. PubMed ID: 10737737
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent changes in bacterial resistance to antibiotics.
    Shaw EJ
    Practitioner; 1974 Oct; 213(1276 SPEC NO):487-93. PubMed ID: 4376234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

  • 10. Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.
    Karlowsky JA; Nichol K; Zhanel GG
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S58-68. PubMed ID: 26316559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current data on antibiotic sensitivity of microflora causing otorhinolaryngologic diseases. 1. Antibiotic sensitivity of Staphylococci and Streptococci].
    Povolotskiĭ IaL
    Zh Ushn Nos Gorl Bolezn; 1979; (1):83-9. PubMed ID: 375612
    [No Abstract]   [Full Text] [Related]  

  • 12. The antibacterial activity of a new 3-azinomethyl-rifamycin.
    Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N
    Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y
    J Antibiot (Tokyo); 1970 Mar; 23(3):137-48. PubMed ID: 4394125
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
    Biedenbach DJ; Arhin FF; Moeck G; Lynch TF; Sahm DF
    Int J Antimicrob Agents; 2015 Dec; 46(6):674-81. PubMed ID: 26541881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 17. SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocci.
    Kitzis MD; Goldstein FW; Ishida N; Acar JF
    J Antimicrob Chemother; 1995 Jul; 36(1):209-13. PubMed ID: 8537267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic antimicrobial susceptibility and occurrence of selected resistance genes in gram-positive mastitis pathogens isolated from Wisconsin dairy cows.
    Ruegg PL; Oliveira L; Jin W; Okwumabua O
    J Dairy Sci; 2015 Jul; 98(7):4521-34. PubMed ID: 25912858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of laboratory guidance to antibiotic therapy.
    Isenberg HD
    Health Lab Sci; 1967 Jul; 4(3):166-80. PubMed ID: 4382258
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological characterization of prasinomycin, a phosphorus-containing antibiotic.
    Meyers E; Miraglia GJ; Smith DA; Basch HI; Pansy FE; Trejo WH; Donovick R
    Appl Microbiol; 1968 Apr; 16(4):603-8. PubMed ID: 5647519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.